首页> 外国专利> Recombinant Protein Bodies as Immunogen-Specific Adjuvants

Recombinant Protein Bodies as Immunogen-Specific Adjuvants

机译:重组蛋白体作为免疫原特异性佐剂

摘要

An immunogen-specific is adjuvant for a vaccine or inoculum is disclosed. The adjuvant is comprised of particulate recombinant protein body-like assemblies (RPBLAs) that contain a recombinant fusion protein that contains two portions peptide-linked together. A first portion is a protein body-inducing sequence (PBIS) and a second portion is a T-cell stimulating immunogenic polypeptide whose sequence is that of a pathogenic polypeptide sequence present in or induced by a vaccine or inoculum. The adjuvant, when used as an inoculum in a host animal without a prior priming vaccination or inoculation, does not induce production of antibodies or T cell activation to the pathogenic sequence.
机译:公开了针对疫苗或接种物的免疫原特异性佐剂。佐剂由微粒重组蛋白体样组件(RPBLA)组成,其中包含重组融合蛋白,重组融合蛋白包含两个肽段连接在一起的部分。第一部分是蛋白体诱导序列(PBIS),而第二部分是T细胞刺激免疫原性多肽,其序列是疫苗或接种物中存在的或由疫苗或接种物诱导的病原性多肽序列的序列。佐剂在没有事先接种疫苗或接种的情况下用作宿主动物的接种物时,不会诱导抗体产生或对病原体序列的T细胞活化。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号